Treatment Options In Adult Chronic Idiopathic Thrombocytopenic Purpura: Panel Discussion

Treatment options in adult chronic idiopathic thrombocytopenic purpura: Panel discussion

Considerations for Treating ITP in the Future

Novel promising agents for the treatment of ITP

VJHemOnc – Video Journal of Hematology & HemOnc

First-Line Therapy Options for Patients with ITP

Immune Thrombocytopenic Purpura (ITP) - Causes, Pathogenesis, Signs & Symptoms, Diagnosis, Treatment

The Platelet Couch ITP Panel Discussion

Doptelet® (avatrombopag)

Treating Persistent/Chronic ITP Current Care, Future Potential

ISTH

Advice for ITP Patients: Madonna

Platelet Disorder Support Association

Treating Persistent/Chronic ITP - Current Care, Future Potential

Rutgers Robert Wood Johnson Department of Medicine

Immune Thrombocytopenic Purpura (iTTP) Panel Discussion: Delay in Diagnosis - Why?

The France Foundation

How is ITP Treated?

Platelet Disorder Support Association

ITP Treatment Selection Criteria and Treatment Goals

Immune Thrombocytopenia: First-Line Treatment Options

Targeted Oncology

Immune Thrombocytopenic Purpura (iTTP) Panel Discussion: Multidisciplinary Collaboration

The France Foundation

Key Insights: Real-World Evidence for ITP Treatment

New Rules for Overcoming ITP

PeerView Oncology

Diagnosing Idiopathic Thrombocytopenia Purpura

ITP Pathogenesis, Presentation, and Diagnostic Workup

What symptoms do people with ITP experience?

Differential Diagnosis of Immune Thrombocytopenia